XML 81 R54.htm IDEA: XBRL DOCUMENT v3.20.4

Capital Management (Tables)

12 Months Ended

Dec. 31, 2020

Corporate Information And Statement Of IFRS Compliance [Abstract]

Schedule of Total Capital

For regulatory reporting purposes under the LICAT framework, there were further adjustments, including goodwill, non-life investments, and others as was prescribed by OSFI, to the total capital figure presented in the table below:

As at December 31,			2020						2019
Subordinated debt						$	4,781					$	3,538
Innovative capital instruments(1)						200						200
Equity:
Preferred shareholders’ equity						2,257						2,257
Common shareholders’ equity						22,212						21,141
Participating policyholders’ equity						1,368						1,091
Non-controlling interests’ equity						25						19
Total capital						$	30,843					$	28,246

(1)    Innovative capital instruments are SLEECS issued by SLCT I (Note 13). SLCT I is not consolidated by us.

X

- Definition

Corporate Information And Statement Of IFRS Compliance [Abstract]

+ References

No definition available.

+ Details

Name:	slf_CorporateInformationAndStatementOfIFRSComplianceAbstract
Namespace Prefix:	slf_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Disclosure Of Total Capital [Table Text Block]

+ References

No definition available.

+ Details

Name:	slf_DisclosureOfTotalCapitalTableTextBlock
Namespace Prefix:	slf_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration